36th Annual HLA & Transplant Workshop

The Scottsdale Resort at McCormick Ranch • Scottsdale, Arizona

MAR 7 - 10, 2022

Submit a compelling HLA Case Study for an opportunity to present at our 2022 Workshop!

One Lambda would like to give you an opportunity to present at our 36th Annual HLA & Transplant Workshop. To participate you must submit a compelling case study relevant to the work you do in the lab. Applicants must be currently working in a histocompatibility and immunogenetics laboratory in the United States or Canada.

Entry Rules (Click to view)

Submission Deadline: Monday, January 17, 2022
Selected submissions will be announced: Friday, February 4, 2022

Chosen Entries Receive

Submit your HLA Case Study for an opportunity to present at our Annual HLA & Transplant Workshop. Applicants must meet the Rules & Qualifications.

  • Complimentary coach airfare
  • Four nights stay at:
    The Scottsdale Resort at McCormick Ranch in Scottsdale, Arizona.

Selection Criteria

Selection of submission will be based upon review by a panel of five HLA professionals (not employed by One Lambda). Five cases will be selected for presentation. Entries will be selected on the following criteria:

  • Contribution
  • Innovation
  • Relevance
  • Quality
  • Clarity
  • Completeness
  • Impact on the Transplant Clinical Field

Rules & Qualifications

  1. Applicants must reside in one of the 50 United States, a US Territory, or Canada
  2. Applicants must be currently employed by an accredited clinical laboratory
  3. Managers, supervisors, and HLA technologists are eligible
  4. All entries must include:
    1. Cover page, with your full name, laboratory name, location, email address, and contact phone number
    2. Submissions must be summarized on one page (graphs, tables, and diagrams are acceptable)
  5. You will be required to present in PowerPoint
  6. Presentation length may not exceed 15 minutes
  7. Applicants are eligible to enter ONE submission only
  8. Multiple applicants from the same lab are acceptable
  9. No group entries

*Participation is not intended to induce the purchase of any Thermo Fisher products. Read Long-Form Rules


Workshop Agenda

Times listed below are in Pacific Standard Time (PST).

March 7, 2022 | Monday

1:00 PM - 5:00 PM

Workshop Registration (Coronado Link)

6:00 PM - 8:00 PM

Welcome Reception (Bennie’s Courtyard)

March 8, 2022 | Tuesday

7:00 AM - 7:45 AM

Breakfast (Coronado IV & V)

8:00 AM

Introduction & Welcome (Coronado I-III)


Sarah MacLeod

8:15 AM - 10:15 AM

2022 Paul I. Terasaki Antibody Lecture (Coronado I-III)


Annette Jackson


Adam Bingaman
Myths and Realities: Lessons Learned from Over 650 Kidney Paired Donor Transplants at a Single Center Program

Massimo Mangiola
Redesigning HLA Compatibility: From a Concept to Reality

10:15 AM - 10:45 AM

Coffee Break

10:45 AM - 12:45 AM

Directors Abstract Session I


Robert Bray

1:00 PM - 2:00 PM

Lunch (Sunset Plaza)

2:00 PM - 6:00 PM

Free Afternoon

6:00 PM - 7:00 PM

Evening Session (Coronado I-III)


Laurine Bow


Rob Carroll
A 2020 Banff Antibody Mediated Injury Working Group Examination of International Practices for Diagnosing Antibody-Mediated Rejection in Kidney Transplantation

March 9, 2022 | Wednesday

7:00 AM - 7:45 AM

Breakfast (Coronado IV & V)

8:00 AM - 10:00 AM

Diversity in the HLA Laboratory (Coronado I-III)


Mary Philogene


Edgar Milford
Diversity, Equity and Access to Transplant

Cathi Murphey Half
Changes to KAS and its Impact to Diversity in Allocation

John Lunz & Hasan Khamash
Center Experiences with Allocation

10:00 AM - 10:30 AM

Coffee Break

10:30 AM - 12:30 PM

HLA Case Studies


Donna L. Phelan

Harriet Noreen


Selected submissions will be announced at a later date

12:30 PM - 1:30 PM

Lunch ~ What's New at OLI (Sunset Plaza)

1:30 PM - 6:00 PM

Free Afternoon

12:30 PM - 1:30 PM

Networking ~ Group Dinner (Paradise Park Lawn)

March 10, 2022 | Thursday

7:00 AM - 7:45 AM

Breakfast (Coronado IV & V)

8:00 AM - 10:00 AM

New Advances in Bone Marrow Transplantation (Coronado I-III)


Neng Yu


Effie Petersdorf
B Leader Sequences and Survivorship after HLA-Mismatched Unrelated Donor Transplantation

Brian Shaffer
Allogeneic HCT Donor Selection Based on KIR and HLA Genotypes

Stefan Ciurea
Treatment of Allosensitized Patients Receiving Allogeneic Transplantation

10:00 AM - 10:30 AM

Coffee Break

10:30 AM - 12:30 AM

Directors Abstract Session II


Daniel Ramon

12:30 PM - 1:30 PM

Lunch ~ Workshop Concludes (Sunset Plaza)

Share This Page

Workshop Speakers (Click to view)

Adam Bingaman, MD | Methodist Specialty and Transplant Hospital – San Antonio, TX

Annette Jackson, PhD | Duke University – Durham, NC

Brian Shaffer, MD | Memorial Sloan Kettering Cancer Research Center – New York, NY

Cathi Murphey Half, PhD | Southwest Immunodiagnostics Laboratory – San Antonio, TX

Donna L. Phelan, BA, MT(HEW), CHS(ABHI) | Barnes-Jewish Hospital  St. Louis, MO

Edgar Milford, MD | Brigham & Women’s Hospital – Boston, MA

Effie Petersdorf, MD | Seattle Cancer Care Alliance – Seattle, WA

Harriet Noreen, BS, CHS(ABHI) | Fairview Hospital - Minneapolis, MN

Hasan Khamash, MD | Mayo Clinic Arizona – Phoenix, AZ

John Lunz, PhD | LifeLink Foundation – Tampa, FL

Laurine Bow, PhD | Yale University School of Medicine – New Haven, CT

Mary Philogene, PhD | American Red Cross – Philadelphia, PA

Massimo Mangiola, PhD | NYU Langone Health – New York, NY

Rob Carroll, MD | Australian Red Cross – Melbourne, Australia

Robert Bray, PhD | Emory University Hospital – Atlanta, GA

Sarah MacLeod | Director, Customer Experience, Thermo Fisher Scientific - West Hills, California

Stefan Ciurea, MD | Professor of Clinical Medicine

Neng Yu, PhD | University of Mass Memorial Medical Center – Boston, MA